Efe, C. Et Al. 2022. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. LIVER INTERNATIONAL , vol.42, no.3 , 607-614.

Efe, C., Lammert, C., Tascilar, K., Dhanasekaran, R., Ebik, B., Higuera-de la Tijera, F., ... Caliskan, A. R.(2022). Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis. LIVER INTERNATIONAL , vol.42, no.3, 607-614.

Efe, Cumali Et Al. "Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis," LIVER INTERNATIONAL , vol.42, no.3, 607-614, 2022

Efe, Cumali Et Al. "Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis." LIVER INTERNATIONAL , vol.42, no.3, pp.607-614, 2022

Efe, C. Et Al. (2022) . "Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis." LIVER INTERNATIONAL , vol.42, no.3, pp.607-614.

@article{article, author={Cumali Efe Et Al. }, title={Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis}, journal={LIVER INTERNATIONAL}, year=2022, pages={607-614} }